Cost Is One of the Biggest Barriers to Myfortic Adherence

You know the clinical importance of Myfortic (Mycophenolic Acid) in your transplant patients' immunosuppressive regimens. But clinical efficacy means nothing if your patient can't afford to fill the prescription.

Brand-name Myfortic runs $750–$900 per month without insurance. Even with coverage, high copays, prior authorization hurdles, and formulary restrictions can put this medication out of reach. For transplant patients, non-adherence to immunosuppression isn't just a compliance issue — it's a direct path to graft loss.

This guide outlines the savings programs, generic options, and practical strategies you can use to help your patients keep taking the medication they need.

What Your Patients Are Actually Paying

Understanding the cost landscape helps frame the conversation:

• Brand-name Myfortic (360 mg, 60 tablets): $750–$900/month at retail
• Generic Mycophenolic Acid DR (360 mg, 60 tablets) at retail without coupons: $500–$855/month
• Generic with discount coupons (GoodRx, SingleCare, etc.): $43–$100/month
• With commercial insurance: Variable; copays may range from $10–$200+ depending on formulary tier and plan design
• Medicare Part D: Generally covered for generic, but prior authorization is common; patients may hit coverage gaps

The spread between retail generic ($500+) and coupon-discounted generic ($43) is striking. Many patients don't know that a free coupon card can save them hundreds of dollars per month. That's where your guidance comes in.

Manufacturer Savings Programs

Novartis SaveOnMyPrescription.com

Novartis offers a co-pay savings program for brand-name Myfortic through SaveOnMyPrescription.com. Key details:

• Available to patients with commercial insurance
• Reduces out-of-pocket copay costs
• Patients can check eligibility online at saveonmyprescription.com
• Not available to patients on government insurance (Medicare, Medicaid, Tricare, VA)

For patients whose insurance covers brand-name Myfortic but with a high copay, this can make a meaningful difference.

Novartis Patient Assistance Foundation (NPAF)

For patients who are uninsured or underinsured and cannot afford their medication:

• Provides free medication to eligible patients
• Apply at patient.novartis.com or call 1-800-277-2254
• Available to all payer types, including Medicare and Medicaid patients who meet income criteria
• Requires documentation of financial need

This is one of the most impactful programs available. If you have patients who are rationing doses or skipping refills due to cost, this should be your first recommendation.

Coupon and Discount Cards

For patients filling generic Mycophenolic Acid delayed-release tablets, discount cards can dramatically reduce out-of-pocket costs — often below their insurance copay:

• GoodRx: Prices as low as $43–$100 for 60 tablets of generic Mycophenolic Acid DR 360 mg
• SingleCare: Comparable pricing at major pharmacy chains
• RxSaver, Optum Perks, BuzzRx: Additional options worth comparing

Key Points for Your Practice

• Coupon cards work at the pharmacy counter — no enrollment forms or approval process
• They're free for patients to use
• Patients cannot combine coupon cards with insurance — it's one or the other at the point of sale
• Sometimes the coupon price beats the insurance copay, especially for patients on high-deductible health plans
• Coupon purchases do not count toward insurance deductibles or out-of-pocket maximums

Consider having your staff check coupon prices when patients report cost barriers. A 30-second GoodRx search can identify hundreds of dollars in monthly savings.

Generic Alternatives and Therapeutic Substitution

Generic Mycophenolic Acid Delayed-Release

Generic Mycophenolate Sodium (Mycophenolic Acid delayed-release tablets) is available from multiple manufacturers, including Mylan (Viatris). For most patients, the generic is clinically equivalent and significantly cheaper:

• Same active ingredient and enteric-coated delayed-release formulation
• FDA-approved as therapeutically equivalent (AB-rated)
• Retail price: $500–$855 without coupons; $43–$100 with coupons

If your patient is currently on brand-name Myfortic and struggling with cost, switching to the generic is the most straightforward intervention.

Therapeutic Substitution: CellCept (Mycophenolate Mofetil)

If Myfortic or its generic is unavailable or too expensive even with coupons, Mycophenolate Mofetil (CellCept and generics) is a therapeutic alternative worth considering:

• Same active metabolite (MPA), different prodrug formulation
• Generic Mycophenolate Mofetil is widely available and often cheaper
• Dosing is not equivalent — Myfortic 720 mg is roughly equivalent to CellCept 1,000 mg in MPA exposure, but this is not a 1:1 conversion. Dose adjustments and monitoring are required.
• CellCept may cause more GI side effects in some patients due to the lack of enteric coating
• Switching between formulations should include MPA level monitoring during the transition period

For a detailed clinical comparison, see our provider guide on managing Myfortic shortages.

Other Immunosuppressant Alternatives

For patients who cannot tolerate any mycophenolate product:

• Azathioprine (Imuran): Older, less potent, but well-established and inexpensive. May be appropriate for low-immunologic-risk patients.
• Everolimus (Zortress): mTOR inhibitor; different mechanism. Higher cost but may be appropriate in specific clinical scenarios.
• Belatacept (Nulojix): IV infusion, monthly dosing after loading. Useful for calcineurin inhibitor–intolerant patients.

For a comprehensive overview of alternatives, see our guide on Myfortic alternatives.

Additional Resources

• NeedyMeds.org — Comprehensive database of patient assistance programs
• RxAssist.org — Patient assistance program directory
• RxHope.com — Helps connect patients with manufacturer assistance programs
• Medfinder for Providers — Locate pharmacies with Myfortic in stock and access tools to help patients find their medications

Building Cost Conversations Into Your Workflow

Cost discussions shouldn't be an afterthought. Here's how to systematically address affordability in your transplant clinic:

At Prescribing

• Default to prescribing generic Mycophenolic Acid DR unless there's a clinical reason for brand-name
• Write prescriptions with "substitution permitted" to give the pharmacy flexibility
• Discuss cost proactively — many patients won't bring it up on their own

At Follow-Up

• Ask directly: "Are you having any trouble affording your medications?"
• Watch for indirect signs of cost-related non-adherence: missed refills, declining to fill, splitting doses, or requesting smaller quantities
• Monitor MPA trough levels — unexpectedly low levels may indicate missed doses due to cost

Staff and Workflow

• Train your pharmacy team or care coordinators to check coupon prices as part of standard workflow
• Keep information on the Novartis Patient Assistance Foundation readily available for staff
• Designate a team member to handle prior authorization appeals — denials are common for brand-name Myfortic
• Consider creating a "cost resource sheet" for Myfortic that your staff can hand to patients at the point of prescribing

Prior Authorization Tips

If brand-name Myfortic is required and insurance requires prior authorization:

• Document clinical necessity clearly — especially if the patient has tried generic and experienced issues (GI intolerance, inconsistent absorption, etc.)
• Note if step therapy was attempted (e.g., trial of CellCept with documented GI side effects)
• Include supporting lab work (MPA levels, renal function, graft function)
• Appeal denials promptly — many are overturned on first appeal with adequate documentation

Final Thoughts

Medication cost is a modifiable barrier to transplant outcomes. By integrating cost awareness into your prescribing workflow — defaulting to generics, knowing the savings programs, and asking patients directly about affordability — you can help prevent the graft losses and hospitalizations that result from cost-driven non-adherence.

The tools exist. Generic Mycophenolic Acid with a coupon can cost under $50/month. Patient assistance programs can provide the medication for free. The gap is often just awareness — and that's where you come in.

For more provider resources, visit Medfinder for Providers.